Pharmaceutical Preparations · DE · CIK 1831828
Develops transformative treatments for serious immunological diseases, including atacicept for autoimmune conditions
Comparable business profile · signals at a glance
In the 90 days to Feb 23, 2026: 1 insider bought $250K · 7 sold $2.8M.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Feb 23, 2026 | Fordyce MarshallPRESIDENT AND CEO | Sell | 16,925 | $41.98 | $711K |
| Feb 23, 2026 | Grant SeanCHIEF FINANCIAL OFFICER | Sell | 4,949 | $41.98 | $208K |
| Feb 23, 2026 | Young Joseph RSVP, FINANCE, CHIEF ACCT OFFCR | Sell | 3,117 | $41.98 | $131K |
| Feb 23, 2026 | Johnson David LeeChief Operating Officer | Sell | 2,579 | $41.98 | $108K |
| Feb 23, 2026 | Turner William D.Chief Regulatory Officer | Sell | 2,187 | $41.98 | $92K |
| Feb 23, 2026 | Brenner RobertChief Medical Officer | Sell | 2,151 | $41.98 | $90K |
| Feb 23, 2026 | Skelton Laurence MatthewChief Commercial Officer | Sell | 1,582 | $41.98 | $66K |
| Dec 15, 2025 | Turner William D.Chief Regulatory Officer | Sell | 10,000 | $50.08 | $501K |
| Dec 11, 2025 | Enright Patrick GDirector | Buy | 5,882 | $42.50 | $250K |
| Dec 8, 2025 | Turner William D.Chief Regulatory Officer | Sell | 10,000 | $45.31 | $453K |
| Dec 3, 2025 | Turner William D.Chief Regulatory Officer | Sell | 10,000 | $40.00 | $400K |
| Nov 21, 2025 | Carter Jason SChief Legal Officer | Sell | 3,864 | $27.82 | $107K |
| Nov 11, 2025 | Young Joseph RSVP, FINANCE, CHIEF ACCT OFFCR | Sell | 15,000 | $29.06 | $436K |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.